We therefore favor a model in which transformation of early stage CGNPs into infant medulloblastoma requires SUFU deletion, as this would induce precocious pathway activation independently of a SHH signal, but not SMO activation, which would not have a proliferative effect, possibly as the result of less frequent primary cilium expression (Han et al., 2009). The gene discussed is SUFU; the disease is medulloblastoma.